Implementation of Matrix Organization and New Operating Model for European Operations in Pharma

One of the leading pharmaceutical companies worldwide.

Recent launch of a strategic plan with strong emphasis on putting the patient at the centre and on focusing on offering solutions, implying profound changes in the way of working (cross-collaboration, focus on the customer…), and organisational changes (matrix structure) in a very turbulent market.

The objective of the project was to sustain growth and profitability by ensuring that all country operations felt at ease with the new structure, and quickly adopt new ways of working to accelerate execution and respond to market demands.

Worked with 8 largest countries in Europe to ensure alignment with the new model, to remove personal and organisational barriers to succeed in the new structure and provide individual and team capabilities that will increase speed and quality of the execution.

12-month program with each country which was developed at European level allowing some space for local adjustments to increase relevance.

Main focus was the Board direct reports.

Successful roll-out of the new model in key European markets.

Increased country/team/individual alignment and capabilities to work more collaboratively to effectively respond to a very dynamic and changing market.